viernes, 21 de febrero de 2025

Novo Nordisk shortage of Ozempic and Wegovy ends, threatening compounders Patients have been drawn toward compounded versions based on their cheaper price

https://www.statnews.com/2025/02/21/fda-declares-end-to-semaglutide-shortage-threatens-makers-compounded-version-ozempic-wegovy/

No hay comentarios:

Publicar un comentario